BCO vs BMY · P/E 25, rev $5.01B vs P/E 17, rev $48.19B
Brinks Company (BCO) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BCO and BMY stock pages for the full models.
Not investment advice.